In this episode of Skincare Confidential, Dr. Ted Lain interviews Dr. Michael Gold, a leading expert in dermal fillers and aesthetic medicine. They discuss the evolution of dermal fillers, including the latest innovations in adipose-derived fillers and biostimulatory products. Dr. Gold shares insights on the regulatory landscape for fillers in the US compared to other countries, the importance of skin quality in aesthetic treatments, and the future of regenerative medicine in dermatology. The conversation highlights the growing market for fillers and the exciting developments on the horizon. Takeaways: Dr. Gold has been instrumental in the growth of aesthetic conferences.The US has a limited number of fillers compared to Europe and Asia.Renuva is a unique adipose-derived filler with regenerative properties.Sculptra is a biostimulatory filler that promotes collagen production.Emerging fillers are being developed with innovative combinations of ingredients.Skin quality is becoming a key focus in filler treatments.PDRN shows promise for regenerative skin treatments but is limited in the US.Regulatory hurdles impact the availability of new fillers in the US market.The future of fillers looks promising with many new products on the horizon.Education and clinical trials are essential for the safe use of fillers. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related